News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search Clinical trial to test a new gene therapy in patients with immunodeficiency 13/12/2023 Positive preliminary results of the study of HIPRA's vaccine against COVID-19 05/12/2023 Vall d'Hebron discovers a new antibody for the diagnosis of patients with scleroderma 24/10/2023 The HITIHE project concludes with a meeting of all project members in Antwerp 23/10/2023 RBDCOV members meet at Vall d'Hebron to advance the development of BIMERVAX vaccine 11/10/2023 Bufa la Bombolla raises €12,480 for research in primary immunodeficiencies 14/10/2022 ESPID has awarded a study in which Vall d'Hebron has participated 13/06/2022 A publication of Vall d'Hebron, awarded by 'Anales de Pediatría' 02/06/2022 Blood testosterone as a COVID-19 survival marker in men 19/04/2022 A program to support patients with primary immunodeficiencies at Vall d'Hebron expands to Bellvitge Hospital 19/01/2022 Vall d'Hebron, a reference in care and research in enterovirus infection 29/12/2021 Bufa la Bombolla returns for primary immunodeficiency research 29/11/2021 Vall d'Hebron participates in an international study that associates new genetic and immunological defects with severe COVID-19 18/08/2021 Vall d'Hebron releases four innovative works on different systemic diseases 04/08/2021 Dr. Antoni Soriano, awarded by the European Society of Paediatric Infectious Diseases (ESPID) 12/07/2021 Genetic variations in testosterone receptor predispose to sever COVID-19 in men 22/03/2021 Published the results of the Vall d’Hebron study, which shows that minors are low transmitters of SARS-CoV-2 15/03/2021